- Jason Edward Ochs
- May 9, 2017
A new study in the British Journal of Medicine has resurrected the debate and concern over cardiovascular risk linked to the commonly utilized pain relievers known as nonsteroidal anti-inflammatory drugs, or NSAIDs. The study involved a systematic review of studies…
- Jason Edward Ochs
- May 6, 2017
The U.S. Consumer Product Safety Commission (CPSC) has warned consumers to immediately stop using the LayZ Board self-balancing scooters (also known and sold as hoverboards). The warning follows a tragic house fire on March 10, 2017, in Harrisburg, PA, which…
- Jason Edward Ochs
- May 5, 2017
Yesterday I had blogged about how Johnson & Johnson had set all-time new records for major verdicts against them as a fortune 500 company in 2016. The ink was barely dry when a St. Louis jury awarded a Virginia woman…
- Jason Edward Ochs
- May 4, 2017
Johnson & Johnson once promoted themselves as America’s brand with their commercials of babies and American-like commitment abound years ago, but 2016 has shed a much different light on the company defined by juries across the country, and 2017 could…
- Jason Edward Ochs
- May 1, 2017
A Philadelphia jury awarded a New Jersey woman $20 million after receiving a transvaginal mesh device. The verdict was the third verdict from a Philadelphia jury that levied an 8-figure award against Johnson & Johnson related to one of their…
- Jason Edward Ochs
- April 29, 2017
Depending on where you live in the United States the awareness of ATV safety and ATV danger varies greatly. Perhaps such awareness (or lack thereof) contributes to the death rate that is absolutely alarming with these machines, however the more…
- Jason Edward Ochs
- April 25, 2017
The Food and Drug Administration reports that a rare cancer first linked to breast implants in 2011 has now been linked to nine (9) deaths. As of Feb. 1, the FDA had received a total of 359 reports of the cancer…
- Jason Edward Ochs
- April 25, 2017
GM appealed to the US Supreme Court in an effort to put an end to the lawsuits facing them concerning their alleged coverup and failure to disclose potential knowledge regarding the ignition switch defect that has been alleged to have…
- Jason Edward Ochs
- April 20, 2017
Two bellwether trials are set to begin in the mass action regarding the pharmaceutical drug Xarelto in the coming week. The first will start next week in the Eastern District of Louisiana. To date there are more than 16,000 cases…
- Jason Edward Ochs
- April 16, 2017
The World Health Organization’s International Agency for Research on Cancer (IARC) recently declared the weed killer Roundup a “probable human carcinogen” amidst numerous studies linking it to non-Hodkin’s lymphoma, multiple myeloma, and leukemia. A number of journal reviews have specifically…
